14-12　ⓔ文献

1. Davison JM: Kidney function in pregnant women. Am J Kidney Dis, 1987; 9: 248–252.

2. Alper AB, Yi Y, et al: Performance of estimated glomerular filtration rate prediction equations in preeclamptic patients. Am J Perinatol, 2011; 28: 425–430.

3. Kristensen K, Larsson I, et al: Increased cystatin C expression in the pre-eclamptic placenta. Mol Hum Reprod, 2007; 13: 189–195.

4. 日本妊娠高血圧学会編：妊娠高血圧症候群　新定義・分類 運用上のポイント，メジカルビュー，2019.

5. Levine RJ, Maynard SE, et al: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med, 2004; 350: 672–683.

6. Zeisler H, Llurba E, et al: Predictive Value of the sFlt–1: PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med, 2016; 374: 13–22.

7. 日本妊娠高血圧学会編：妊娠高血圧症候群の診療指針2015，メジカルビュー，2015.

8. Rolnik DL, Wright D, et al: Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med, 2017; 377: 613–622.

9. Smith GC, Pell JP, et al: Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129, 290 births. Lancet, 2001; 357: 2002–2006.

10. 日本腎臓学会学術委員会腎疾患患者の妊娠：診療の手引き改訂委員会編：腎疾患患者の妊娠 診療ガイドライン2017，診断と治療社，2017.

11. Piccoli GB, Attini R, et al: Pregnancy and Chronic Kidney Disease: A Challenge in All CKD Stages. Clin J Am Soc Nephrol, 2010; 5: 844–855.

12. Cooper WO, Hernandez–Diaz S, et al: Major congenital malformations after first–trimester exposure to ACE inhibitors. N Engl J Med, 2006; 354: 2443–2451.

13. Li DK, Yang CM, et al: Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. Br Med J, 2011; 343: d5931.